Sodium 1-hexadecanesulfonate

Published date: 2025-05-08 08:48:00

Sodium 1-hexadecanesulfonate Structure
Share to Facebook Share to Twitter Share to Linkedin
Name Sodium 1-hexadecanesulfonate CAS# 15015-81-3
Price ¥Inquiry/25kg Purity 98.5%
Stocking
Period
Inquiry Stock In Stock
 Detail Product Information
Chemical & Physical Properties:
CAS Number: 15015-81-3
Name: Sodium 1-hexadecanesulfonate
Molecular Formula: C16H33NaO3S
Molecular Weight: 328.48600
Density: N/A
Boiling Point: N/A
Melting Point: 265 °C
Flash Point: N/A

Supplier/Manufacture

Wuhan Yuqing Jiaheng Pharmaceutical Co., Ltd

Chemsrc Level: Unverified
Tel: 027-82753045
Address: B406-410 CITIC Building, Jianghan Economic Development Zone, Jianghan District, Wuhan City, Hubei Province
Area: China
Contact: Andy liu
Contact Phone #: 13037171113
Email: 1050518788@qq.com
Website: http://www.hbzlkschem.com
Foreign Trade % of Sales: 50
Major partners:
Hubei Zhonglong Kangsheng Fine Chemical Ltd Ltd is a comprehensive chemical enterprise dedicated to the research and development, production, and sales of fine chemicals, pharmaceutical intermediates, and dye intermediates.
Hubei Zhonglong Kangsheng Fine ChemicalLtd. covers an area of more than 50 acres and currently has about 200 employees. It has a group of researchers with more than 10 years of research and development experience, as well as marketing and production management personnel, including 2 PhDs, 8 masters, and 7 senior engineers. 80% of the employees have college or vocational education or above. The company has one engineering technology research center and two production bases.
The company has a sound quality assurance system and safety and environmental protection system, and has always focused on product research and development. The company is based on a high starting point and focuses on developing high-tech products with international advanced levels. It has established good cooperative relationships with more than ten colleges and research institutes across the country and has strong capabilities in product research and development, as well as technology transfer. Since its establishment, the company has developed and put into operation more than 20 pharmaceutical raw materials and intermediates. The product is novel and advanced, with strong market competitiveness. The company's products are sold domestically in 28 provinces and cities, and exported to Europe, America, Asia Pacific, and other regions, with export volume accounting for more than 30% of the total products.